2024-04-30 12:49 | CC:CYTO | Cytophage Technologies Ltd | 0.33 | News Release200 | Cytophage Therapeutics releases fiscal 2023 results |
2024-04-16 13:49 | CC:CYTO | Cytophage Technologies Ltd | 0.39 | News Release200 | Cytophage Technologies appoints Cochrane as director |
2024-04-02 12:17 | CC:CYTO | Cytophage Technologies Ltd | 0.57 | News Release200 | Cytophage completes human trial at Ottawa Hospital |
2024-03-01 12:06 | CC:CYTO | Cytophage Technologies Ltd | 0.52 | News Release200 | Cytophage to provide bacteriophages for Cdn patient |
2024-02-12 12:08 | CC:CYTO | Cytophage Technologies Ltd | 0.57 | News Release200 | Cytophage plans field trials of OvaPhage in Canada |
2024-02-07 20:38 | CC:CYTO | Cytophage Technologies Ltd | | News Release200 | Cytophage to start trading on TSX-V Feb. 9 |
2024-02-07 16:23 | CC:CYTO | Cytophage Technologies Ltd | | Resume Trading385 | Cytophage to resume trading Feb. 9 |
2024-02-07 16:22 | CC:CYTO | Cytophage Technologies Ltd | | Private Placement250 | Cytophage 2.5-million-share private placement |
2024-02-07 16:13 | CC:CYTO | Cytophage Technologies Ltd | | Change Name, Roll Back Shares290 | Cytophage Technologies 1:4.1448 share rollback |
2024-02-07 16:11 | CC:CYTO | Cytophage Technologies Ltd | | Qualifying Transaction319 | Cytophage Technologies qualifying transaction |
2024-02-07 16:11 | CC:CIII | Cuspis Capital III Ltd | | Qualifying Transaction319 | Cytophage Technologies qualifying transaction |
2024-02-02 17:22 | CC:CIII | Cuspis Capital III Ltd | | News Release200 | Cuspis Capital III completes RTO with Cytophage |
2024-02-02 11:31 | CC:CIII | Cuspis Capital III Ltd | | News Release200 | Cuspis files filing statement for QT with Cytophage |
2023-12-22 09:08 | CC:CIII | Cuspis Capital III Ltd | | News Release200 | Cuspis Capital III receives cond. OK for Cytophage deal |
2023-11-29 17:46 | CC:CIII | Cuspis Capital III Ltd | | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-29 17:38 | CC:CIII | Cuspis Capital III Ltd | | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-06 14:48 | CC:CIII | Cuspis Capital III Ltd | 0.17 | News Release200 | Cuspis Capital signs merger deal with Cytophage |
2023-08-28 07:34 | CC:CIII | Cuspis Capital III Ltd | 0.17 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-08-28 07:29 | CC:CIII | Cuspis Capital III Ltd | 0.17 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-06-01 10:36 | CC:CIII | Cuspis Capital III Ltd | 0.17 | News Release200 | Cuspis Capital signs LOI for QT with Cytophage |
2023-06-01 07:38 | CC:CIII | Cuspis Capital III Ltd | 0.17 | Halt Trading170 | Cuspis Capital III halted at the open |
2023-05-29 18:17 | CC:CIII | Cuspis Capital III Ltd | 0.125 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-29 18:17 | CC:CIII | Cuspis Capital III Ltd | 0.125 | SEDAR MD & A815 | SEDAR MD & A |